Evidence map›Paper›PMID 23322080›Full record

ReviewObstetrical & gynecological survey2013

Trichomonas vaginalis vaginitis in obstetrics and gynecology practice: new concepts and controversies.

Jenell S Coleman, Charlotte A Gaydos, Frank Witter

Abstract readReview
In one paragraph

Review in Obstetrical & gynecological survey, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 124 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Why Does Trichomonas vaginalis Continue to be a "Neglected" Sexually Transmitted Infection?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
  12. Article
  13. Review
  14. Sexually transmitted diseases and infertility.American journal of obstetrics and gynecology · 2017
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jenell S ColemanDivision of Gynecologic Specialties, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. colemanj@jhmi.edu
Charlotte A Gaydos
Frank Witter
Johns Hopkins Medicine · USOffice of Infectious Diseases · US

Funding

TrainingU54EB007958 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI Susan Anne Tuddenham · 2007 to 2026
$34.6M
HIV Prevention Trials Network: Network LaboratoryU01AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI ESHLEMAN, SUSAN H · 2006 to 2010
$16.5M
NIAID NIH HHS U01 AI068613NIBIB NIH HHS U54 EB007958
6 · The paper itself

Abstract

Trichomonas vaginalis (TV) is the most common curable sexually transmitted infection worldwide. Annually, 7.4 million new infections are estimated in the United States, which is greater than combined new cases of Chlamydia, gonorrhea, and syphilis. Serious adverse reproductive health outcomes including pregnancy complications, pelvic inflammatory disease, and an increased risk of HIV acquisition have been linked to TV infection. There are several sensitive and specific diagnostic tests available, including a newly approved nucleic acid amplification test (NAAT) that utilizes the same instrumentation platform and clinical sample as Chlamydia and gonorrhea tests. In this article, we review TV pathogenicity, adverse reproductive health outcomes, detection, and treatment followed by clinical scenarios for which TV diagnosis may prove useful in obstetrics and gynecology practice.

Indexed as

Pregnancy Complications, InfectiousTrichomonas vaginalisTrichomonas VaginitisAnti-Infective AgentsCoinfectionDirective CounselingFemaleHIV InfectionsHumansMetronidazoleNucleic Acid Amplification TechniquesPelvic Inflammatory DiseasePregnancyPregnancy OutcomeReproductive Health ServicesSexually Transmitted DiseasesAnti-Infective AgentsMetronidazole

Identifiers

PMID23322080
PMCPMC3586271
OpenAlexW2091958454

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.